J. Lambea

3.6k total citations · 1 hit paper
26 papers, 1.0k citations indexed

About

J. Lambea is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, J. Lambea has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in J. Lambea's work include Renal cell carcinoma treatment (7 papers), Colorectal Cancer Treatments and Studies (4 papers) and Colorectal Cancer Surgical Treatments (4 papers). J. Lambea is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Colorectal Cancer Treatments and Studies (4 papers) and Colorectal Cancer Surgical Treatments (4 papers). J. Lambea collaborates with scholars based in Spain. J. Lambea's co-authors include Berta Sáez, A. Trés, África González‐Fernández, Nuria Vilaboa, Manuel Arruebo, Dolores Isla, Javier Martínez‐Trufero, Juan Jesús Cruz, Pablo Maroto and J.L. González-Larriba and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

J. Lambea

25 papers receiving 995 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of the Evolution of Cancer Treatment Therapies

2011 638 citations Berta Sáez, J. Lambea et al. Cancers profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
J. Lambea	333	285	203	184	124	26	1.0k
Qianqian Yu	299 0.9×	319 1.1×	175 0.9×	168 0.9×	69 0.6×	45	1.1k
M Zadinová	521 1.6×	153 0.5×	152 0.7×	125 0.7×	136 1.1×	46	1.1k
Qianqian Yu	552 1.7×	218 0.8×	92 0.5×	184 1.0×	133 1.1×	37	1.0k
Jingjing Xie	470 1.4×	385 1.4×	301 1.5×	276 1.5×	144 1.2×	39	1.2k
Sihem Ait‐Oudhia	389 1.2×	336 1.2×	136 0.7×	102 0.6×	139 1.1×	40	1.1k
Ravi Thakur	466 1.4×	202 0.7×	214 1.1×	104 0.6×	109 0.9×	36	1.2k
Qunyou Tan	438 1.3×	122 0.4×	134 0.7×	140 0.8×	170 1.4×	48	1.0k
Wei Xia	742 2.2×	331 1.2×	236 1.2×	196 1.1×	227 1.8×	44	1.6k
Jon Zugazagoitia	501 1.5×	344 1.2×	299 1.5×	135 0.7×	99 0.8×	14	1.1k
Zeting Yuan	411 1.2×	200 0.7×	148 0.7×	275 1.5×	238 1.9×	31	1.0k

Countries citing papers authored by J. Lambea

Since Specialization

Citations

This map shows the geographic impact of J. Lambea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Lambea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Lambea more than expected).

Fields of papers citing papers by J. Lambea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Lambea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Lambea. The network helps show where J. Lambea may publish in the future.

Co-authorship network of co-authors of J. Lambea

This figure shows the co-authorship network connecting the top 25 collaborators of J. Lambea. A scholar is included among the top collaborators of J. Lambea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Lambea. J. Lambea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deza, Diego Casas, et al.. (2022). Diagnosis of Malnutrition According to GLIM Criteria Predicts Complications and 6-Month Survival in Cancer Outpatients. Biomedicines. 10(9). 2201–2201. 10 indexed citations

Deza, Diego Casas, et al.. (2021). GLIM vs ESPEN criteria for the diagnosis of early malnutrition in oncological outpatients. Clinical Nutrition. 40(6). 3741–3747. 27 indexed citations

Mesı́a, Ricard, L. Iglesias, J. Lambea, et al.. (2021). SEOM clinical guidelines for the treatment of head and neck cancer (2020). Clinical & Translational Oncology. 23(5). 913–921. 64 indexed citations

Deza, Diego Casas, et al.. (2021). Comparation of different malnutrition screening tools according to GLIM criteria in cancer outpatients. European Journal of Clinical Nutrition. 76(5). 698–702. 12 indexed citations

Mesı́a, Ricard, L. Iglesias, J. Lambea, et al.. (2021). Correction to: SEOM clinical guidelines for the treatment of head and neck cancer (2020). Clinical & Translational Oncology. 23(5). 1001–1001. 2 indexed citations

Esteban, Emilio, Francisco Expósito, Guillermo Crespo, et al.. (2021). Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy. Cancers. 13(11). 2849–2849. 13 indexed citations

Puente, Javier, Urbano Anido, Miguel Ángel Climent, et al.. (2020). Expert recommendations on the management of patients with metastatic castration-resistant prostate cancer who progress after CHAARTED or LATITUDE. Therapeutic Advances in Medical Oncology. 12. 3863535107–3863535107. 2 indexed citations

Méndez-Vidal, María José, Urbano Anido, Isabel Chirivella, et al.. (2018). Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma. BMC Pharmacology and Toxicology. 19(1). 77–77. 20 indexed citations

Pérez‐Valderrama, Begoña, J.L. González-Larriba, J. Lambea, et al.. (2017). SPAZO2 (SOGUG): Comparative effectiveness of everolimus (Ev) vs axitinib (Ax) as second-line after first-line pazopanib (1stPz) in metastatic renal carcinoma (mRC). Annals of Oncology. 28. v313–v313. 1 indexed citations

10.

Lambea, J., et al.. (2016). The Wide Experience of the Sequential Therapy for Patients with Metastatic Renal Cell Carcinoma. Current Oncology Reports. 18(11). 66–66. 6 indexed citations

11.

Durán, Ignacio, J. Lambea, Pablo Maroto, et al.. (2016). Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action. Targeted Oncology. 12(1). 19–35. 79 indexed citations

12.

Lambea, J., Núria Laínez, M. Lázaro, et al.. (2012). Quality of life and supportive care for patients with metastatic renal cell carcinoma. Cancer and Metastasis Reviews. 31(S1). 33–39. 10 indexed citations

13.

Martínez‐Trufero, Javier, Dolores Isla, Antonio Irigoyen López, et al.. (2010). Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment. British Journal of Cancer. 102(12). 1687–1691. 38 indexed citations

14.

Martínez‐Trufero, Javier, et al.. (2009). Phase II study of capecitabine as palliative treatment for patients (p) with squamous head and neck cancer (HNC) with locoregional and/or metastatic relapse after previous platinum-based treatment (PBT): Final results of Spanish Head and Neck Cancer Group (TTCC). Journal of Clinical Oncology. 27(15_suppl). 6047–6047. 1 indexed citations

15.

Lopez, Derrick, Marieberta Vidal, Sérgio Serrano, et al.. (2009). Evaluation of neurological symptoms in oncologic patients at the emergency department. Journal of Clinical Oncology. 27(15_suppl). e20728–e20728. 1 indexed citations

16.

Goya, Gerardo F., Iván Marcos-Campos, Rodrigo Fernández‐Pacheco, et al.. (2008). Dendritic cell uptake of iron‐based magnetic nanoparticles. Cell Biology International. 32(8). 1001–1005. 42 indexed citations

17.

Mayordomo, José, Eugenia Ortega, Eduardo Polo, et al.. (2005). Gemcitabine/Capecitabine in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes. Clinical Breast Cancer. 6(2). 158–162. 22 indexed citations

18.

Alonso, Vicente, Antonieta Salud, M. Mira, et al.. (2004). Preoperative chemoradiation with oxaliplatin and 5-fluorouracil in locally advanced rectal carcinoma. Journal of Clinical Oncology. 22(14_suppl). 3607–3607. 5 indexed citations

19.

Alonso, Vicente, Antonieta Salud, P. Escudero, et al.. (2004). Preoperative chemoradiation with oxaliplatin and 5-fluorouracil in locally advanced rectal carcinoma. Journal of Clinical Oncology. 22(14_suppl). 3607–3607. 6 indexed citations

20.

Andrés, Raquel, et al.. (2004). Predictive value of Serum S-100B protein in predicting relapse in patients with melanoma. Journal of Clinical Oncology. 22(14_suppl). 7532–7532. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact